Journal of cardiovascular pharmacology
New Cardioprotective Frontiers in Double Inhibition With SGLT2 and PCSK9 in Cancer Survivors.
Alexander E Berezin
Published: 202510.1097/FJC.0000000000001769
No abstract available for this study.
Alexander E Berezin
No abstract available for this study.